MoneyWorks4Me

Alkem Laboratories informs about disclosure

01 Mar 2025 Evaluate

Pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulations, Alkem Laboratories has informed that the Company has received an order passed by statutory authority under the Goods and Services Tax Act, 2017 and the details as required under Clause 20 of Para A of Part A of Schedule III of SEBI LODR Regulations is enclosed as Annexure A. The Company is in the process of taking appropriate action(s), including but not limited to the filing of an appeal against the order. The above information is also available on the website of the Company at www.alkemlabs.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1836.80
Dr. Reddys Labs. 1159.00
Cipla 1353.30
Lupin 2082.15
Zydus Lifesciences 1117.00
View more..